High mir-30 expression associates with improved breast cancer patient survival and treatment outcome

Show full item record



Permalink

http://hdl.handle.net/10138/332363

Citation

Jamshidi , M , Fagerholm , R , Muranen , T A , Kaur , S , Potdar , S , Khan , S , Netti , E , Mpindi , J-P , Yadav , B , Kiiski , J I , Aittomäki , K , Heikkilä , P , Saarela , J , Bützow , R , Blomqvist , C & Nevanlinna , H 2021 , ' High mir-30 expression associates with improved breast cancer patient survival and treatment outcome ' , Cancers , vol. 13 , no. 12 , 2907 . https://doi.org/10.3390/cancers13122907

Title: High mir-30 expression associates with improved breast cancer patient survival and treatment outcome
Author: Jamshidi, Maral; Fagerholm, Rainer; Muranen, Taru A.; Kaur, Sippy; Potdar, Swapnil; Khan, Sofia; Netti, Eliisa; Mpindi, John-Patrick; Yadav, Bhagwan; Kiiski, Johanna I.; Aittomäki, Kristiina; Heikkilä, Päivi; Saarela, Jani; Bützow, Ralf; Blomqvist, Carl; Nevanlinna, Heli
Contributor: University of Helsinki, HUS Gynecology and Obstetrics
University of Helsinki, HUS Gynecology and Obstetrics
University of Helsinki, HUS Gynecology and Obstetrics
University of Helsinki, Faculty Common Matters
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, HUS Gynecology and Obstetrics
University of Helsinki, HUS Gynecology and Obstetrics
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Helsinki Institute of Life Science HiLIFE
University of Helsinki, INDIVIDRUG - Individualized Drug Therapy
University of Helsinki, Medicum
University of Helsinki, HUSLAB
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, HUSLAB
University of Helsinki, Medicum
University of Helsinki, HUS Gynecology and Obstetrics
Date: 2021-06
Language: eng
Number of pages: 15
Belongs to series: Cancers
ISSN: 2072-6694
URI: http://hdl.handle.net/10138/332363
Subject: BRCA2 MUTATIONS
EPITHELIAL-MESENCHYMAL TRANSITION
HER-2
HYBRIDIZATION
INVASION
METASTASIS
MICRORNAS
PROGNOSTIC-FACTORS
PROTEIN EXPRESSION
RESISTANCE
SUPPRESS
anthracycline
breast cancer
chemotherapy
doxorubicin
lapatinib
metastasis
miR-30
p53
survival
3122 Cancers
3123 Gynaecology and paediatrics
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
cancers_13_02907_v2.pdf 2.205Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record